Drug intelligence / Profile preview

rabies vaccine (Bharat Biotech)

Development stage
Approved
Lead developer
Bharat Biotech
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular, Intradermal
01

Overview

Indirab is a purified Vero cell rabies vaccine (PVRV) containing the inactivated Pitman-Moore strain of the rabies virus. Developed and manufactured by Bharat Biotech, it is indicated for both pre-exposure prophylaxis and post-exposure treatment of rabies in humans. The vaccine is produced by cultivating the virus in Vero cell cultures, followed by purification and inactivation with beta-propiolactone. Upon administration, Indirab stimulates the host immune system to produce specific neutralizing antibodies that provide active immunity against the rabies virus, a member of the Lyssavirus genus. It is recognized for its high potency and safety profile, serving as a modern alternative to older nerve-tissue-derived vaccines. The vaccine is typically administered via intramuscular or intradermal routes according to World Health Organization (WHO) recommended schedules.

Brand names
Indirab
Other names
Purified Vero Cell Rabies VaccinePVRVInactivated Rabies Vaccine

Beyond the preview

Go deeper on rabies vaccine (Bharat Biotech).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rabies vaccine (Bharat Biotech).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call